Fenuril

Quick links to important sections

Fenuril

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fenuril

What is Fenuril? Defining the Topical Oxidizing Agent

Property Description
Active ingredient Carbamide Peroxide, Sodium Chloride
Form Solution, Gel
Pharmacological class Oxidizing Agent, Topical Antiseptic
General use Local hygiene, Cerumen softening
Origin Synthetic and inorganic salt combination

Fenuril is a combination medicinal preparation primarily classified as a topical oxidizing agent and antiseptic, intended for localized surface application. This medicine is defined by its ability to facilitate chemical cleansing and control surface microorganisms in a localized area. The ingredient Carbamide Peroxide is recognized as an active ingredient in Over-the-Counter (OTC) otic drug products used as an earwax removal aid.


Composition and Available Forms: Carbamide Peroxide and Sodium Chloride

The active core of Fenuril consists of the two functional ingredients: Carbamide Peroxide (also known as urea-hydrogen peroxide) and Sodium Chloride, typically supplied in a liquid solution or gel dosage form. Carbamide Peroxide is a stable compound designed for controlled release of the active agents upon contact with moisture. This controlled mechanism is clinically recognized for its reliable action in breaking down and softening compacted debris.

Sodium Chloride is included as an inorganic salt that acts as an electrolyte and osmotic agent, crucial for stabilizing the preparation and ensuring hydration of the application site. The typical presentation of this formulation as an otic solution differentiates its primary patient group, positioning it for adults and older children seeking local hygiene and cerumen management. This composition dictates that Fenuril is strictly administered via the topical route to the affected area.


General Purpose: What is Fenuril Used for on a Basic Level?

The general purpose of Fenuril is to promote localized hygiene and assist in the physical breakdown and removal of certain undesirable organic matter. This function is accomplished through the effervescent action resulting from the controlled release of oxygen, which gently lifts and dislodges surface debris. The preparation is consequently used to facilitate the softening and mechanical clearance of thickened accumulations, such as dried and impacted earwax (cerumen). This specific, mild, cleansing action is its fundamental therapeutic purpose, contributing to local comfort and cleanliness.

What side effects are possible with Fenuril?

Possible side effects and safety information for Fenuril

Official safety documentation for products marketed under the name Fenuril in certain jurisdictions, which may be sold for moisturising or dermatological purposes, indicates a generally well-known and low-risk profile for its key active substance, urea (carbamide), when used topically at standard concentrations (e.g., 5% or 10%). Urea's safety profile is supported by extensive regulatory review for non-prescription dermatological use.

Adverse Reactions Scope

Classification Example Reactions (Typically Urea) Significance
Common Transient local skin reactions, such as mild irritation, stinging, or redness at the application site. Usually mild and temporary.
Rare Allergic contact dermatitis, severe hypersensitivity reactions. Requires immediate discontinuation and medical review.

System-organ classes involved: Primarily Skin and subcutaneous tissue disorders (local irritation, pruritus, erythema).

Dose- or exposure-related patterns: The incidence of local stinging or irritation may be higher when applied to damaged or highly sensitive skin or when using higher concentrations of urea.

Safety-related restrictions or limitations: Avoid contact with eyes, mucous membranes, and open wounds. Regulatory guidance specifies that the product is for external use only. Some formulations may contain other excipients that carry their own specific, low-incidence safety warnings, which must be detailed in the product information.

High-Level Safety Notes

  • Regulatory Basis: The safety profile for urea in dermatological products is considered well-established based on decades of international use and regulatory review (e.g., in the EU and by health authorities for similar reference products).
  • Monitoring Notes: No specific additional pharmacovigilance or risk minimisation beyond routine measures is typically proposed by regulators for standard-concentration urea products, affirming its generally favourable safety status.

Connection to the overall safety profile: The official safety profile for Fenuril, based on its established composition containing urea, structures the understanding of risks predominantly around predictable, mild, and reversible local skin reactions. Severe systemic or serious adverse events are not typically associated with the appropriate topical use of this formulation, placing its risks in the minor, local irritation category. Safety monitoring is routine due to the well-known properties of the active ingredient.

Overdose and Emergency Response

Overdose and when to seek help

The overdose profile for Fenuril, a topical oxidizing agent, is primarily concerned with accidental oral ingestion of the solution. Documented overdose manifestations in regulatory sources range from localized gastrointestinal symptoms, such as stomach upset, vomiting, and throat irritation, to severe chemical burns of the mouth, esophagus, and stomach.

A critical systemic life-threat associated with ingestion is the potential for gas embolism, which occurs when liberated oxygen bubbles enter the bloodstream. This can lead to serious vascular complications, including stroke or heart attack.

Due to these severe risks, regulatory authorities mandate strict emergency actions. If Fenuril is swallowed, individuals are instructed to seek emergency medical attention or contact a Poison Control Center right away. In cases of severe exposure, symptomatic and supportive care is the official management strategy, as no specific antidote is known. Clinical monitoring involves assessing vital signs and performing diagnostic tests to evaluate internal burns.

Additionally, regulatory documentation emphasizes that the product must be kept far away from the reach of young children to prevent accidental ingestion.

Therapeutic Uses of Fenuril

What Fenuril Treats: Main Uses and Benefits

Easing Discomfort from Ear Fullness and Physical Obstruction

The primary therapeutic role of this topical oxidizing preparation is commonly used as an aid to soften and loosen excessive earwax. It is relevant for managing symptoms related to physical discomfort associated with the physical obstruction of the external auditory canal. Fenuril provides support for the uncomfortable feelings of pressure and aural fullness that arise when the ear canal becomes blocked.

Management of Hardened and Compacted Earwax

Fenuril is commonly used in situations involving compacted debris, specifically conditions characterized by periods of heightened symptoms where the cerumen has become notably hardened. This treatment helps in softening and loosening this impacted material. The preparation supports patients during episodes of heightened discomfort, relevant when symptoms interfere with daily functioning. The preparation may be part of symptomatic management when hardened cerumen is the source of noticeable discomfort.

Supportive Relief for Temporary Hearing Difficulty

This solution is relevant for managing the functional consequences of a blocked canal, particularly the temporary symptoms that interfere with daily functioning, such as conductive hearing difficulty. In situations involving obstruction, this preparation supports the patient during difficult episodes and may assist with supporting general comfort when auditory symptoms are present.


Quick Fact: Relief for Aural Fullness

Fenuril may assist with supporting general comfort when auditory symptoms are present, particularly the sensation of a stuffed or clogged ear. It contributes to easing the overall symptom load associated with a physically obstructed ear canal.

Regulatory References

  1. NIH DailyMed Drug Facts

Eligibility and Restrictions for Use

Eligibility Profile for Fenuril (Fenofibrate)

Official regulatory information strictly defines which populations are eligible to use Fenuril and which are formally excluded. This guidance is based on health conditions, physiological status, and age, as documented in authoritative government sources.

Absolute Contraindications (Must NOT Use)

Fenuril is contraindicated and must not be used by specific patient groups, including:

  • Patients diagnosed with severe renal dysfunction (including those on dialysis).
  • Individuals with active liver disease or unexplained persistent liver function abnormalities.
  • Patients with pre-existing gallbladder disease.
  • Nursing mothers (breastfeeding women).
  • Any person with a known hypersensitivity to fenofibrate or its components.

Restricted and Non-Established Use

Population Category Regulatory Status
Pediatric Patients Safety and effectiveness have not been established; use is not recommended.
Mild/Moderate Renal Impairment Requires dose reduction; use is conditional on the degree of impairment.
Pregnancy Use is advised only if the potential benefit justifies the potential risk to the fetus.
Geriatric Patients Use is permitted, but dose selection must be based on a thorough assessment of renal function.

These official rules define the specific boundaries of the eligible adult patient population for Fenuril treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information describes specific constraints regarding the co-administration of Fenuril with several medicine classes and products.

Key Interaction Categories

Interacting Product Category Interaction Implication
HMG-CoA Reductase Inhibitors (Statins) / Colchicine Increased risk of muscle disorders (myopathy/rhabdomyolysis), requiring monitoring.
Oral Anticoagulants (e.g., Coumarin derivatives) Potentiated anticoagulant effect, necessitating a reduction in the anticoagulant's dose to prevent bleeding.
Bile Acid Binding Resins Reduced absorption of Fenuril, requiring doses to be separated by several hours.
Iodinated Contrast Media Increased risk of acute renal dysfunction, requiring Fenuril to be discontinued before and after the procedure.
Other Glucose-Lowering Agents (e.g., Insulin, Sulfonylureas) Increased risk of low blood sugar (hypoglycemia).

Additional Constraints

Regulatory documents mandate specific management strategies for certain concurrent uses. For example, procedures involving iodinated contrast media require the drug to be temporarily discontinued and only restarted after renal function is confirmed to be normal. Furthermore, co-administration with renally excreted cationic drugs (such as cimetidine or cephalexin) may increase the Fenuril concentration by interfering with its elimination. Patients are also advised to avoid excessive alcohol intake due to a heightened risk of a serious adverse event related to metabolism.

Mechanism of Action

️ Chemical Fragmentation and Oxidation Cascade

The mechanism involves a local physicochemical cascade, where active agents structurally fragment and physically separate biological debris, rather than modulating systemic physiological pathways. The core mechanism involves the controlled decomposition of Carbamide Peroxide, releasing Hydrogen Peroxide and Urea. This initiates a local oxidation cascade that chemically cleaves the rigid disulfide bonds within the keratin proteins of impacted debris. The chemical attack and protein denaturation structurally fragment the cohesive mass, altering the material's rigidity and solubility.

Osmotic Permeabilization and Softening

The Sodium Chloride component activates a complementary osmotic action, drawing water into the compacted debris matrix. This process, known as matrix permeabilization, softens the mass and increases its volume. This effect facilitates a greater penetration depth of the oxidizing agents and supports the chemical disintegration of the inner core.

️ Effervescence: The Mechanical Lifting Force

As the chemical breakdown progresses, the rapid liberation of oxygen gas within the softened debris generates micro-effervescence. This mechanical action creates a physical force that lifts and separates the fragmented material from the epithelial surface of the ear canal. This final cascade step provides the mechanical separation necessary for the clearance of the broken-down biological matter.

Dosage and Administration Information

Application Method

Fenuril is a medicated cream intended for topical use on the skin. It is typically applied to the affected areas in a thin layer. For optimal absorption, the cream should be gently rubbed into the skin until it is no longer visible on the surface.

Frequency of Use

The frequency of application is determined based on the condition of the skin. It is common practice to apply the cream several times a day, particularly after the skin has been in contact with water, such as after washing, bathing, or showering. Consistent application helps maintain skin hydration and supports the barrier function of the skin.

Application to Specific Areas

When applying Fenuril, care should be taken to avoid contact with the eyes, nostrils, mouth, or other mucous membranes. If the cream accidentally comes into contact with these areas, they should be rinsed thoroughly with water.

Duration of Use

Fenuril can be used as part of a long-term skin care routine for individuals with dry skin conditions. The duration of use depends on the persistence of the symptoms and the individual response to the cream.

Recent Clinical Evidence

Research evidence / Overview of studies for Fenuril

Evidence for use in Excessive, Hardened, or Impacted Cerumen

This section summarizes the structure of clinical research, primarily focusing on short-term Randomized Controlled Trials (RCTs) and systematic reviews that have evaluated research exploring how the agent affects cerumen softening or clearance.

Research was studied for its evaluation in conditions marked by functional limitations, particularly those linked to compacted earwax. Studies monitored outcomes related to physical discomfort and outcomes reflecting daily functioning, such as temporary difficulties in hearing. Short-term RCTs, often evaluating the agent against other products or non-active solutions, were observed in some research scenarios. Findings describe patterns observed in the studies related to the proportion of patients observing complete cerumen clearance, particularly when the drops were used prior to an irrigation procedure.

Comparative Studies and Measured Outcomes

Fenuril's key active ingredient, Carbamide Peroxide, was evaluated in trials that explored it alongside a range of other common cerumenolytic products, as well as against non-active substances like saline or plain water. The main outcomes studied were based on objective scoring systems used to assess the physical state of the earwax and the measured rate of removal. Evidence is limited and heterogeneous regarding the consistency of results when this agent was evaluated against simple, non-active liquids used for cerumen softening. Findings were mixed across studies when this agent was evaluated alongside other active treatments.

Research on Long-Term Outcomes and Follow-up Duration

The majority of research focusing on earwax removal involved follow-up durations that were limited, typically ranging from a single, short application up to a defined treatment interval of less than one week. This short-term focus reflects research exploring immediate, acute changes related to the physical clearance process. Research has not been widely conducted to monitor whether this preparation was associated with long-term differences in the recurrence of hardened or impacted earwax over extended time intervals.

Key Studies & References FDA DailyMed Drug Facts: Carbamide Peroxide Otic Drug Products for Earwax Removal Aid

Frequently Asked Questions (FAQ)

Common questions about Fenuril (FAQ)

Q: Do I need a prescription from a doctor to get Fenuril?

A: The active ingredient in Fenuril, Carbamide Peroxide otic solution, is generally recognized by the U.S. Food and Drug Administration (FDA) as an Over-the-Counter (OTC) drug product. OTC status means the medicine is typically available for purchase without a prescription for its intended use as an earwax removal aid.


Q: Are there different strengths or formulations of Fenuril?

A: According to official product information, Fenuril is described as being available in both an Otic Solution (liquid drops) and a Gel formulation. While the two primary active ingredients, Carbamide Peroxide and Sodium Chloride, remain the same, the specific concentration and strength are defined in the medicine's official product label.


Q: Can older adults use Fenuril safely?

A: Regulatory documents indicate that the use of this medicine in geriatric patients is generally permitted. However, official guidance specifies that dose selection must be based on a thorough assessment of renal function, as kidney function can change with age.


Q: Is Fenuril generally considered suitable for children?

A: The official label describes the otic solution's use for adults and children aged 12 years and older. However, regulatory texts for the systemic form of Fenuril state that safety and effectiveness have not been established for younger pediatric patients.


Q: What are the ingredients in Fenuril besides the main active component?

A: The two main active components are Carbamide Peroxide and Sodium Chloride. In addition to these, regulatory documents require that all other inactive ingredients, known as excipients (such as stabilizers or preservatives), also be fully detailed in the product's official labeling.


Q: Can Fenuril be taken by people with kidney problems?

A: The systemic form of this medicine is contraindicated, meaning its use is not recommended for patients diagnosed with severe renal dysfunction, which includes those on dialysis. For individuals with mild or moderate kidney impairment, official guidance requires a dose reduction to manage potential risks.


Q: Is Fenuril suitable for people who have liver conditions?

A: Official eligibility documents state that Fenuril is contraindicated for individuals with active liver disease or unexplained persistent liver function abnormalities.


Q: What is the recommended way to store Fenuril?

A: Official guidance states the product must be kept in the original container to protect it from light and moisture. It must be stored at controlled room temperature, typically 20 C to 25 C (or 68 F to 77 F), and must not be frozen.


Q: Does Fenuril have an effect on blood pressure?

A: While the topical solution is non-systemic, the regulatory label for the systemic component notes that caution is required in patients experiencing hypotension (low blood pressure). This is mentioned in the context of general risk, not as a primary effect of the topical preparation.


Q: Is there a particular time of day that is best for taking Fenuril?

A: The official regimen requires application twice daily. This structured schedule is typically described in official materials as being in the morning and evening.


Q: How does the drug information describe Fenuril's effect on blood sugar levels?

A: Regulatory documents describe a potential interaction when the medicine is used at the same time as other glucose-lowering agents. In this scenario, there is an increased risk of low blood sugar (hypoglycemia).


Q: Are there specific dietary restrictions mentioned for Fenuril?

A: Official documents describe a risk of a serious adverse event related to metabolism, which is why excessive alcohol intake is not recommended. No other general dietary restrictions are mentioned.


Q: What kind of studies have been performed on Fenuril?

A: Research summarized in official documents has focused primarily on short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies explored outcomes related to the medicine's ability to soften and aid in the clearance of earwax.


Q: Does Fenuril have any effect on fertility?

A: Regulatory documents for the active ingredient's topical application note that there are no known side effects reported in relation to fertility.


Q: What should a person know about Fenuril if they have a history of heart issues?

A: The official label for the systemic component requires caution for patients with a history of certain heart issues, such as bradyarrhythmia (slow heart rhythm), because the drug may potentially worsen these pre-existing conditions.


Q: Can Fenuril affect my ability to drive or operate machinery?

A: Regulatory documents mention dizziness as a possible side effect associated with the otic solution. If dizziness occurs, the official label suggests caution regarding operating machinery.


Q: What happens in the body when Fenuril starts working?

A: The medicine begins a local oxidation cascade that chemically breaks down the proteins in the earwax. This action is complemented by the creation of micro-effervescence (the release of oxygen gas) which gently creates a physical force to lift and separate the fragmented material.


Q: How long can a person safely take Fenuril?

A: The official regimen defines the treatment course limit as four consecutive days.


Q: What should I do if I miss a scheduled dose of Fenuril?

A: The official protocol directs resuming the schedule normally and cautions against attempting to double the application to compensate for the missed time.


Q: How long does Fenuril stay in your system after stopping treatment?

A: The medicine's mechanism of action is described as a local physicochemical cascade that primarily affects the earwax and does not modulate systemic physiological pathways. This indicates that the effects are short-lived and confined to the site of application.


Q: What happens if I take Fenuril past its expiration date?

A: Official guidance mandates that using the product past its expiration date is outside the defined protocol, and expired product must be returned to a pharmacist or designated collection program for proper disposal.


Q: Is it normal to feel tired after starting Fenuril?

A: Regulatory documents list dizziness as a possible side effect of the otic solution. Although generalized tiredness is not specifically listed, dizziness may be interpreted as a change in general feeling or alertness.


Q: Does Fenuril have a generic version available?

A: The main active ingredient in Fenuril, Carbamide Peroxide, is available in multiple generic Over-The-Counter (OTC) products that are recognized by the FDA.


Q: Is Fenuril associated with any long-term side effects?

A: Studies summarized in regulatory documents indicate that research on long-term outcomes and follow-up duration has not been widely conducted. The existing research focuses primarily on immediate, acute changes related to physical clearance.


Q: Are there specific laboratory tests required while taking Fenuril?

A: Regulatory documents mandate specific patient monitoring for those taking the medicine concurrently with certain other products. This monitoring, which can involve lab work, is required to check for an increased risk of conditions like muscle disorders.

How should Fenuril be stored and disposed of?

How to Store and Dispose of Fenuril?

This information details the officially documented storage, handling, and disposal requirements for Fenuril, as established by governmental regulatory agencies.

Mandatory Storage Requirements

Requirement Statement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep in the original, tightly closed container to protect the medicine from light and moisture.
Prohibition Do not freeze Fenuril.

Handling and Disposal Protocol

  • Child Safety: The medicine must be kept out of the sight and reach of children.
  • Disposal: Do not dispose of unused or expired Fenuril in household trash or pour it down a sink or toilet.
  • End-of-Life: Return the product to a pharmacist or designated collection program to ensure proper disposal according to environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fenuril found in:

A-Z Index: